Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention.

Y-L Kuo, S-J Shieh, H-Y Chiu, J-W Lee
Author Information
  1. Y-L Kuo: Division of Plastic and Reconstructive Surgery, Department of Surgery, National Cheng Kung University Hospital, Dou-Liou Branch, 345 Chuang-Ching Road, Dou-Liou, 640, Taiwan.

Abstract

Necrotizing fasciitis is a soft-tissue infection with a high risk of fatality. Infection with Vibrio vulnificus can lead to development of necrotizing fasciitis and primary septicemia, and occurs mostly in immunocompromised host-associated diseases such as hepatic disease, diabetes mellitus, chronic renal insufficiency, and adrenal insufficiency. Early recognition and treatment of the infection, which are unclear, are vital to patient welfare. We studied the disease epidemiology and reviewed the prognosis and clinical features of patients treated using our developed protocol. Clinical manifestations and outcomes were retrospectively analyzed for 67 patients with V. vulnificus-mediated necrotizing fasciitis and sepsis. All patients who had contacted seawater or raw seafood with positive culture for vibrio were included. Patients were divided into two groups based on the timing of first fasciotomy and injury; within 24 h (group A) and beyond 24 h (group B). Twenty-three of the 67 patients (40%) had hepatic disease, 17 (25.4%) had chronic renal insufficiency, and 12 (17.9%) exhibited adrenal insufficiency. The most common site of infection was the upper extremity (74.7%). Group B presented with more clinical symptoms including fever (p = 0.02), hemorrhagic bullae (p < 0.0001), and shock (p = 0.007). Group A patients exhibited enhanced survival compared to group B (in hospital mortality: 4.9% vs. 23%; p = 0.005). We conclude that early and appropriate diagnosis for V. vulnificus infection should be made, especially in patients presenting with atypical clinical findings. Early fasciotomy within 24 h remains the highest priority and decreases the mortality rate.

References

  1. J Bone Joint Surg Am. 2003 Aug;85-A(8):1454-60 [PMID: 12925624]
  2. J Bone Joint Surg Am. 2004 Nov;86-A(11):2497-502 [PMID: 15523024]
  3. Emerg Infect Dis. 2004 Aug;10(8):1363-8 [PMID: 15496235]
  4. Antimicrob Agents Chemother. 2002 Nov;46(11):3580-4 [PMID: 12384368]
  5. Pediatr Pulmonol. 2000 May;29(5):400-3 [PMID: 10790253]
  6. J Intern Med. 2002 Aug;252(2):107-13 [PMID: 12190885]
  7. Infect Immun. 1997 Sep;65(9):3713-8 [PMID: 9284142]
  8. J Infect Dis. 1999 Jan;179(1):275-8 [PMID: 9841854]
  9. Arch Intern Med. 2006 Oct 23;166(19):2117-23 [PMID: 17060542]
  10. Environ Res. 2007 Mar;103(3):390-6 [PMID: 16949069]
  11. Ann Intern Med. 1988 Aug 15;109(4):318-23 [PMID: 3260760]
  12. J Eur Acad Dermatol Venereol. 2006 Apr;20(4):365-9 [PMID: 16643131]
  13. FEMS Immunol Med Microbiol. 2002 Jun 3;33(2):133-8 [PMID: 12052568]
  14. J Am Coll Surg. 1996 Oct;183(4):329-34 [PMID: 8843261]
  15. Clin Infect Dis. 1992 Aug;15(2):271-6 [PMID: 1520762]
  16. Rev Infect Dis. 1988 May-Jun;10(3):614-5 [PMID: 3293163]
  17. J Microbiol Immunol Infect. 2003 Jun;36(2):81-8 [PMID: 12886957]
  18. J Clin Pharmacol. 1997 Apr;37(4):344-50 [PMID: 9115061]
  19. Am Surg. 2002 Feb;68(2):109-16 [PMID: 11842952]
  20. Pediatrics. 1988 Nov;82(5):784-6 [PMID: 3186359]
  21. Taiwan Yi Xue Hui Za Zhi. 1987 Apr;86(4):448-51 [PMID: 3598555]
  22. Ann Surg. 1996 Apr;223(4):428-33 [PMID: 8633922]
  23. Arch Surg. 1988 Feb;123(2):245-9 [PMID: 3341906]
  24. Arch Intern Med. 1991 Aug;151(8):1606-9 [PMID: 1872665]
  25. N Engl J Med. 1979 Jan 4;300(1):1-5 [PMID: 758155]
  26. Antimicrob Agents Chemother. 1998 Jun;42(6):1319-22 [PMID: 9624467]
  27. Curr Opin Infect Dis. 2001 Apr;14(2):127-32 [PMID: 11979121]
  28. Ann Surg. 1996 Nov;224(5):672-83 [PMID: 8916882]
  29. Antimicrob Agents Chemother. 1997 Oct;41(10):2214-7 [PMID: 9333050]
  30. Epidemiol Infect. 2005 Jun;133(3):383-91 [PMID: 15962544]

MeSH Term

Adult
Aged
Arm
Diabetes Complications
Fasciitis, Necrotizing
Female
Humans
Male
Middle Aged
Retrospective Studies
Sepsis
Subcutaneous Tissue
Taiwan
Vibrio Infections
Vibrio vulnificus

Word Cloud

Created with Highcharts 10.0.0patientsfasciitisinfectioninsufficiencyclinicalp0disease24hgroupB=NecrotizingVibriovulnificusnecrotizinghepaticchronicrenaladrenalEarlytreatmentepidemiology67Vfasciotomywithin179%exhibitedGroupfindingssoft-tissuehighriskfatalityInfectioncanleaddevelopmentprimarysepticemiaoccursmostlyimmunocompromisedhost-associateddiseasesdiabetesmellitusrecognitionunclearvitalpatientwelfarestudiedreviewedprognosisfeaturestreatedusingdevelopedprotocolClinicalmanifestationsoutcomesretrospectivelyanalyzedvulnificus-mediatedsepsiscontactedseawaterrawseafoodpositiveculturevibrioincludedPatientsdividedtwogroupsbasedtimingfirstinjurybeyondTwenty-three40%254%12commonsiteupperextremity747%presentedsymptomsincludingfever02hemorrhagicbullae<0001shock007enhancedsurvivalcomparedhospitalmortality:4vs23%005concludeearlyappropriatediagnosismadeespeciallypresentingatypicalremainshighestprioritydecreasesmortalityratecausedvulnificus:prevention

Similar Articles

Cited By